Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 15, 2023

Adaptive vs Conventional Cardiac Resynchronisation Therapy in Patients With Heart Failure

The Lancet


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
Lancet 2023 Aug 24;[EPub Ahead of Print], BL Wilkoff, G Filippatos, C Leclercq, MR Gold, AS Hersi, K Kusano, W Mullens, GM Felker, C Kantipudi, MF El-Chami, V Essebag, B Pierre, F Philippon, F Perez-Gil, ES Chung, J Sotomonte, S Tung, B Singh, B Bozorgnia, S Goel, HH Ebert, N Varma, KJ Quan, F Salerno, B Gerritse, J van Wel, DE Schaber, DH Fagan, D Birnie

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading